Application | Comment | Organism |
---|---|---|
drug development | biological activity of uridine moiety in naturally occurring non-specific MraY inhibitors (like liposidomycins and caprazamycins), antibacterial chemotherapy against pathogenic bacteria being multiresistant to common antibiotics | Bacteria |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-(uracilylpentyl)-beta-D-O-(5-amino-5-deoxyribosyl)-L-serine | synthesis of analogue of naturally occurring inhibitors like liposidomycins and caprazamycins in which uridine moiety is replaced by a C5 acyclic alkyl chain, and uracil, aminoribose and amino acid moieties are retained | Bacteria |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bacteria | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
MraY | - |
Bacteria |
MraY translocase | - |
Bacteria |